Thus, T cells in tumor-rich regions were dominated by TH,57− (56.6 ± 16.4% out of all CD3+ cells), and TC,57− (28.7 ± 10.6%) while the CD57 positive subsets constituted 4.6 ± 3.1% and 8.3 ± 8.9%, respectively (TH,57+ and TC,57+) (Supplementary Materials Table S5). This evidence concerns the gene B3GAT1 and neoplasm.